Pathogenetic and Combined Treatment of Iron Deficiency Anemia with Drugs Increasing Erythropoiesis

Authors

  • Gulshanoi Akmaljonovna Karimkulova 3rd stage Master of Hematology and Transfusion
  • Yuldasheva Nodira Ergashevna Candidate of medical sciences, associate professor department of hospital therapy and endocrinology Andijan State Medical Institute

Keywords:

hepcidin, iron amounts, transport protein

Abstract

An increase in the amount of iron in the body leads to stimulation of the synthesis of hepcidin, which reduces iron absorption in the intestine, transport and circulation. In turn, a decrease in iron absorption in the intestine leads to inhibition of hepcidin synthesis in the liver and, in feedback, to the restoration of iron uptake from food and intestines. So far, antibodies against hepcidin have not been obtained and it is not possible to measure its level in a clinical setting. Work in this direction is underway.

Downloads

Published

2023-05-13

How to Cite

Gulshanoi Akmaljonovna Karimkulova, & Yuldasheva Nodira Ergashevna. (2023). Pathogenetic and Combined Treatment of Iron Deficiency Anemia with Drugs Increasing Erythropoiesis. Zeta Repository, 20, 98–100. Retrieved from https://zetarepo.com/index.php/zr/article/view/1973

Issue

Section

Articles